48 results
Page 2 of 3
POS AM
mbr6nxzm vcgib7c0t
30 Mar 22
Prospectus update (post-effective amendment)
7:32am
10-K
21wrm
29 Mar 22
Annual report
5:29pm
8-K
EX-99.1
s7nkv3i7pa
29 Mar 22
Pardes Biosciences Reports Full Year 2021 Financial Results and Provides Business Update
4:05pm
424B3
8oybg f0ouv
2 Mar 22
Prospectus supplement
4:23pm
8-K
EX-99.1
q7xqjq5 9b9amus7
2 Mar 22
Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board
4:16pm
8-K
EX-99.2
klj7lwuhup187d
14 Feb 22
Regulation FD Disclosure
7:26am
424B3
4p6bllnod402 xsj
1 Feb 22
Prospectus supplement
5:03pm
8-K
EX-99.1
twcka
7 Jan 22
Regulation FD Disclosure
7:00am
8-K
EX-99.1
rmv50xyjdk4iq
30 Dec 21
Entry into a Material Definitive Agreement
4:55pm
8-K
ovv8itz
30 Dec 21
Entry into a Material Definitive Agreement
4:55pm
424B3
ib2a n7e9c8
1 Dec 21
Prospectus supplement
12:06pm
425
EX-99.1
8r3zsyx27c56rngv7
18 Nov 21
Business combination disclosure
9:14am
8-K
EX-99.1
iex41j 242
18 Nov 21
Regulation FD Disclosure
9:02am
S-4/A
wew 17arefqdix8v8
14 Sep 21
Registration of securities issued in business combination transactions (amended)
6:45am
S-4
tbx22a7opgn
4 Aug 21
Registration of securities issued in business combination transactions
3:02pm